Alzheon IPO To Fund New Phase III Trialling Of Failed Alzheimer's Drug

 
• By Sten Stovall
SC1803_Alzheimers_677117209 _1200.jpg
Alzheon May Need Higher IPO Funding Target If Extra Alzheimer's Trial Needed • Source: Shutterstock

More from Clinical Trials

More from R&D